A Case of Multifocal Adenoid Cystic Carcinoma of the Breast: Using Immunohistochemical Diagnosis to Guide Conservative Management

一例乳腺多灶性腺样囊性癌:应用免疫组化诊断指导保守治疗

阅读:1

Abstract

Adenoid cystic carcinoma (ACC) of the breast is exceptionally rare and can be misdiagnosed as a more aggressive triple-negative subtype. A 56-year-old woman presented with a painless lesion in the right breast. Imaging (Breast Imaging Reporting and Data System (BI-RADS) 5 mammography and ultrasound) identified four multifocal nodules in the upper outer quadrant at the 10 o'clock position, and core needle biopsies confirmed ACC via immunohistochemistry (negative estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2)/neu; positive CD117, cytokeratin 7 (CK7), calponin). She underwent bracket‑guided partial mastectomy with clear margins, followed by adjuvant radiotherapy. Histopathology revealed a 2.5 cm Nottingham Grade I ACC (pT2 pN0 M0) and a 6 mm focus of ductal carcinoma in situ. Despite receptor negativity, endocrine therapy was recommended. Precise immunoprofiling differentiates ACC from basal-like cancers, enabling conservative management. Our case highlights a rare multifocal presentation of ACC managed conservatively with a favorable short-term outcome. This case adds to growing evidence suggesting that, with accurate immunohistochemical diagnosis and multidisciplinary care, breast-conserving surgery may be a safe option in select patients with multifocal ACC. Further multicenter studies are needed to establish management guidelines.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。